-
Retirement
The Fed, Mortgage Rates, and Home Prices – Center for Retirement Research
I recently spoke with a couple who were looking to sell their home. Their real estate agent told them the…
Read More » -
HEALTHCARE & MEDICARE
As healthcare and biopharmaceutical companies embrace artificial intelligence, insurance underwriters see risks and opportunities
The development of precision medicine has transformed the life sciences industry. The identification of disease-associated biomarkers and genes may not…
Read More » -
Retirement
Why financial planning is the ultimate marshmallow test
The Marshmallow Test is a psychological experiment designed to determine a person's ability to delay gratification and plan for a…
Read More » -
HEALTHCARE & MEDICARE
Why “time to value” is the No. 1 metric healthcare AI customers care about
Digital health funding has remained steady this year, with artificial intelligence startups increasingly receiving a larger share of venture capital…
Read More » -
HEALTHCARE & MEDICARE
UHC taps Aeroflow Health to provide virtual nutrition services
UnitedHealthcare has formed a national partnership with Aeroflow Health to provide virtual nutrition services to members, the companies announced last…
Read More » -
HEALTHCARE & MEDICARE
UCB drug becomes first FDA-approved drug to treat extremely rare and fatal mitochondrial disease
The energy that powers the body's cells comes from tiny cellular components called mitochondria. Just as a drained battery makes…
Read More » -
HEALTHCARE & MEDICARE
The future of professional nursing: APP, MD, and machine-guided supervision
Across the United States, health systems are turning to advanced practice providers (APPs) to address an escalating crisis in access…
Read More » -
HEALTHCARE & MEDICARE
Artificial Intelligence Makes FDA’s Current Drug Approval Process Obsolete – Healthcare Blog
Steven Zecora Artificial Intelligence (“AI”) has taken root in the field of drug discovery and development and is showing signs…
Read More » -
HEALTHCARE & MEDICARE
Is Mark Cuban wrong about employers, PBMs and drug prices?
Mark Cuban has been railing against self-insured employers for some time, saying they have more power than any politician to…
Read More » -
HEALTHCARE & MEDICARE
Sarepta sees path to full FDA approval for muscle disease drug despite Phase 3 trial failure
Two of Sarepta Therapeutics' drugs to treat different genetic subtypes of Duchenne muscular dystrophy in patients failed to pass the…
Read More »